Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist.

× No keyword cloud information.

12 in total

Review 1. Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors: E D Harris
Journal: N Engl J Med Date: 1990-05-03 Impact factor: 91.245

Review 2. Lessons for joint destruction from animal models.

Authors: W B van den Berg
Journal: Curr Opin Rheumatol Date: 1997-05 Impact factor: 5.006

3. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors: A Larsen; K Dale; M Eek
Journal: Acta Radiol Diagn (Stockh) Date: 1977-07

4. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.

Authors: A Bendele; T McAbee; G Sennello; J Frazier; E Chlipala; D McCabe
Journal: Arthritis Rheum Date: 1999-03

5. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee.

Authors: A C Bakker; L A Joosten; O J Arntz; M M Helsen; A M Bendele; F A van de Loo; W B van den Berg
Journal: Arthritis Rheum Date: 1997-05

6. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group.

Authors: G V Campion; M E Lebsack; J Lookabaugh; G Gordon; M Catalano
Journal: Arthritis Rheum Date: 1996-07

7. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis.

Authors: B E Drevlow; R Lovis; M A Haag; J M Sinacore; C Jacobs; C Blosche; A Landay; L W Moreland; R M Pope
Journal: Arthritis Rheum Date: 1996-02

Review 8. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

Authors: W P Arend; J M Dayer
Journal: Arthritis Rheum Date: 1995-02

9. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.

Authors: L A Joosten; M M Helsen; F A van de Loo; W B van den Berg
Journal: Arthritis Rheum Date: 1996-05

10. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Authors: D T Felson; J J Anderson; M Boers; C Bombardier; M Chernoff; B Fried; D Furst; C Goldsmith; S Kieszak; R Lightfoot
Journal: Arthritis Rheum Date: 1993-06

13 in total

1. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

Authors: P Barrera; L A Joosten; A A den Broeder; L B van de Putte; P L van Riel; W B van den Berg
Journal: Ann Rheum Dis Date: 2001-07 Impact factor: 19.103

Review 2. Immune-related gene polymorphisms in pulmonary diseases.

Authors: Dhirendra P Singh; Prathyusha Bagam; Malaya K Sahoo; Sanjay Batra
Journal: Toxicology Date: 2017-03-30 Impact factor: 4.221

3. A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown.

Authors: C J Proctor; C Macdonald; J M Milner; A D Rowan; T E Cawston
Journal: Arthritis Rheumatol Date: 2014-04 Impact factor: 10.995

4. Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis.

Authors: Ke Rui; Zhijiang Zhang; Jie Tian; Xiang Lin; Xiaohui Wang; Jie Ma; Xinyi Tang; Huaxi Xu; Liwei Lu; Shengjun Wang
Journal: Cell Mol Immunol Date: 2015-09-21 Impact factor: 11.530

5. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.

Authors: L Danks; A Sabokbar; R Gundle; N A Athanasou
Journal: Ann Rheum Dis Date: 2002-10 Impact factor: 19.103

6. Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials.

Authors: Muhammad Sajid Hamid Akash; Kanwal Rehman; Ni Li; Jian-Qing Gao; Hongying Sun; Shuqing Chen
Journal: Pharm Res Date: 2012-08-21 Impact factor: 4.200

Review 7. Update on synovitis.

Authors: Z Szekanecz; A E Koch
Journal: Curr Rheumatol Rep Date: 2001-02 Impact factor: 4.686

8. The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases.

Authors: Chul-Su Yang; Dong-Min Shin; Eun-Kyeong Jo
Journal: Int Neurourol J Date: 2012-03-31 Impact factor: 2.835

9. Analgesic, anti-inflammatory and anti-pyretic activities of Caesalpinia decapetala.

Authors: Amna Parveen; Muhammad Sajid Hamid Akash; Kanwal Rehman; Qaisar Mahmood; Muhammad Imran Qadir
Journal: Bioimpacts Date: 2014-04-10

10. Association of IL-1A and IL-1B polymorphisms with ankylosing spondylitis among the Chinese Han population: a case-control study.

Authors: Lei Li; Baolan Shi; Wenkai Zheng; Wenhua Xing; Yan Zhao; Feng Li; Daqi Xin; Tianbo Jin; Yong Zhu; Xuejun Yang
Journal: Oncotarget Date: 2017-04-25